User profiles for Hlin Kvartsberg

Hlin Kvartsberg, PhD

Senior researcher and head of assay development, Neurochemical pathophysiology and …
Verified email at neuro.gu.se
Cited by 1809

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative

…, P Saha-Chaudhuri, F Lussier, H Kvartsberg… - Molecular …, 2021 - nature.com
Whilst cerebrospinal fluid (CSF) and positron emission tomography (PET) biomarkers for
amyloid-β (Aβ) and tau pathologies are accurate for the diagnosis of Alzheimer’s disease (AD), …

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

H Kvartsberg, FH Duits, M Ingelsson, N Andreasen… - Alzheimer's & …, 2015 - Elsevier
… Author links open overlay panel Hlin Kvartsberg a 1 , Flora H. Duits b 1 , Martin Ingelsson
c , Niels Andreasen d , Annika Öhrfelt a , Kerstin Andersson a , Gunnar Brinkmalm a , Lars …

Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease

…, S Janelidze, R Ossenkoppele, H Kvartsberg… - Brain, 2021 - academic.oup.com
It is currently unclear how amyloid-β and tau deposition are linked to changes in synaptic
function and axonal structure over the course of Alzheimer’s disease. Here, we assessed these …

[HTML][HTML] Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

…, B Olsson, K Höglund, NC Cullen, H Kvartsberg… - Acta …, 2018 - Springer
Neurogranin (Ng) is a post-synaptic protein that previously has been shown to be a biomarker
for synaptic function when measured in cerebrospinal fluid (CSF). The CSF concentration …

[HTML][HTML] Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease

K Hellwig, H Kvartsberg, E Portelius… - Alzheimer's research & …, 2015 - Springer
Introduction Neuroinflammation and synaptic degeneration are major neuropathological
hallmarks in Alzheimer’s disease (AD). Neurogranin and YKL-40 in cerebrospinal fluid (CSF) …

[HTML][HTML] Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy …

H Kvartsberg, E Portelius, U Andreasson… - Alzheimer's research & …, 2015 - Springer
Introduction Synaptic dysfunction and degeneration are central events in Alzheimer’s disease
(AD) pathophysiology that are thought to occur early in disease progression. Synaptic …

[HTML][HTML] Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

…, X Shao, S Havlicek, NR Dunn, H Kvartsberg… - Molecular …, 2021 - nature.com
A population of more than six million people worldwide at high risk of Alzheimer’s disease (AD)
are those with Down Syndrome (DS, caused by trisomy 21 (T21)), 70% of whom develop …

CSF synaptic biomarkers in the preclinical stage of Alzheimer disease and their association with MRI and PET: a cross-sectional study

M Milà-Alomà, A Brinkmalm, NJ Ashton, H Kvartsberg… - Neurology, 2021 - AAN Enterprises
Background and Objectives To determine whether CSF synaptic biomarkers are altered in
the early preclinical stage of the Alzheimer continuum and associated with Alzheimer disease …

[HTML][HTML] Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation

…, J Strandberg, TO Bontell, H Kvartsberg… - Scientific reports, 2016 - nature.com
Amyloid precursor protein (APP) and its cleavage product amyloid β (Aβ) have been thoroughly
studied in Alzheimer’s disease. However, APP also appears to be important for neuronal …

Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology

…, Z Zhang, B Xie, J Peng, O Hansson, H Kvartsberg… - Brain, 2020 - academic.oup.com
To date, there is no validated fluid biomarker for tau pathology in Alzheimer’s disease, with
contradictory results from studies evaluating the correlation between phosphorylated tau in …